Nutra Pharma Corp. (NPHC) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Nutra Pharma Corp.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 618,010 1.43M 159,599 203,290 122,198
Cost of Goods Sold (COGS) incl. D&A 278,944 616,612 879,587 147,647 41,165
COGS excluding D&A 273,126 601,447 863,529 132,653 26,184
Depreciation & Amortization Expense 5,818 15,165 16,058 14,994 14,981
Depreciation 5,818 15,165 16,058 14,994 14,981
Amortization of Intangibles 0 0 0 - 0
Gross Income 339,066 815,444 (719,988) 55,643 81,033
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 2.42M 4.14M 3.23M 2.66M 2.44M
Research & Development 222,558 191,786 90,865 3,046 697
Other SG&A 2.2M 3.95M 3.14M 2.65M 2.44M
Other Operating Expense 0 0 0 0 0
Unusual Expense 150,000 0 22,577 950,815 1.84M
EBIT after Unusual Expense (150,000) 0 (22,577) (950,815) (1.84M)
Non Operating Income/Expense 0 334,979 0 93,035 19,178
Non-Operating Interest Income 0 0 - 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 69,003 74,283 424,038 153,472 157,376
Gross Interest Expense 69,003 74,283 424,038 153,472 157,376
Interest Capitalized 0 0 0 0 0
Pretax Income (2.3M) (3.06M) (4.4M) (3.61M) (4.34M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (2.3M) (3.06M) (4.4M) (3.61M) (4.34M)
Minority Interest Expense 0 0 0 0 0
Net Income (2.3M) (3.06M) (4.4M) (3.61M) (4.34M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - - 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (2.3M) (3.06M) (4.4M) (3.61M) (4.34M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (2.3M) (3.06M) (4.4M) (3.61M) (4.34M)
EPS (Basic) (0.01) (0.01) (0.01) (0.01) (0.01)
Basic Shares Outstanding 230.48M 275.15M 297.73M 403M 743.49M
EPS (Diluted) (0.01) (0.01) (0.01) (0.01) (0.01)
Diluted Shares Outstanding 230.48M 275.15M 297.73M 403M 743.49M
EBITDA (2.08M) (3.31M) (3.93M) (2.59M) (2.35M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Nutra Pharma Corp.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 618,010 1.43M 159,599 203,290 122,198
Cost of Goods Sold (COGS) incl. D&A 278,944 616,612 879,587 147,647 41,165
COGS excluding D&A 273,126 601,447 863,529 132,653 26,184
Depreciation & Amortization Expense 5,818 15,165 16,058 14,994 14,981
Depreciation 5,818 15,165 16,058 14,994 14,981
Amortization of Intangibles 0 0 0 - 0
Gross Income 339,066 815,444 (719,988) 55,643 81,033
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 2.42M 4.14M 3.23M 2.66M 2.44M
Research & Development 222,558 191,786 90,865 3,046 697
Other SG&A 2.2M 3.95M 3.14M 2.65M 2.44M
Other Operating Expense 0 0 0 0 0
Unusual Expense 150,000 0 22,577 950,815 1.84M
EBIT after Unusual Expense (150,000) 0 (22,577) (950,815) (1.84M)
Non Operating Income/Expense 0 334,979 0 93,035 19,178
Non-Operating Interest Income 0 0 - 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 69,003 74,283 424,038 153,472 157,376
Gross Interest Expense 69,003 74,283 424,038 153,472 157,376
Interest Capitalized 0 0 0 0 0
Pretax Income (2.3M) (3.06M) (4.4M) (3.61M) (4.34M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (2.3M) (3.06M) (4.4M) (3.61M) (4.34M)
Minority Interest Expense 0 0 0 0 0
Net Income (2.3M) (3.06M) (4.4M) (3.61M) (4.34M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - - 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (2.3M) (3.06M) (4.4M) (3.61M) (4.34M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (2.3M) (3.06M) (4.4M) (3.61M) (4.34M)
EPS (Basic) (0.01) (0.01) (0.01) (0.01) (0.01)
Basic Shares Outstanding 230.48M 275.15M 297.73M 403M 743.49M
EPS (Diluted) (0.01) (0.01) (0.01) (0.01) (0.01)
Diluted Shares Outstanding 230.48M 275.15M 297.73M 403M 743.49M
EBITDA (2.08M) (3.31M) (3.93M) (2.59M) (2.35M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
